Autism Biomarker Consortium for Clinical Trials (ABC-CT)
Child Development & Autism
What is the purpose of this trial?
This is a multicenter longitudinal study that aims to identify, develop and validate a set of measures that can be used as stratification biomarkers and/or sensitive and reliable objective measures of social impairment in autism spectrum disorders (ASD) that could serve as markers of long term clinical outcome. The main study will include 275 individuals: 200 ASD subjects between 6-11 years old, and 75 TD subjects roughly matched by age and sex to the ASD group.
- Ages6 - 11 years
- Trial withNational Institute of Mental Health (NIMH)
- Start Date09/20/2016
- End Date11/29/2019
- Last Updated10/11/2018
- Study HIC#1701018759